Vaxxinity Inc.
05/09/2024 | Press release | Distributed by Public on 05/09/2024 14:27
Termination Notice - Form 15-12G
vaxxform1512g
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATIONAND NOTICE OF TERMINATIONOF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934OR
SUSPENSION OF DUTY TO FILE REPORTSUNDER SECTIONS 13 AND 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-41058
VAXXINITY,INC.
(Exact name of registrant as specified in its charter)
505 Odyssey Way
Merritt Island, FL 32953
(254) 244-5739
(Address, including zip code, and telephone number,
including area code, of registrant's principal executiveoffices)
Class A Common Stock, par value $0.0001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities forwhich
a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon toterminate or
suspend the duty to file reports:
Rule 12g-4(a)(1)
☒
Rule 12g-4(a)(2)
☐
Rule 12h-3(b)(1)(i)
☒
Rule 12h-3(b)(1)(ii)
☐
Rule 15d-6
☐
Rule 15d-22(b)
☐
Approximate number of holders of record as of the certification or notice date: 171
Pursuant to the requirements of the Securities Exchange Act of 1934,as amended, Vaxxinity,Inc. has caused
this certification/notice to be signed on its behalf by the undersigned duly authorizedperson.
Date: May 9, 2024
By:
/s/ Mei Mei Hu
Name:
Mei Mei Hu
Title:
Chief Executive Officer